HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Pharmaceuticals	36.10B	20.54B	15.56B
Pharmaceuticals Growth	75.75%	32.03%	-
Total	36.10B	20.54B	15.56B
Total Growth	75.75%	32.03%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
South Korea	36.10B	20.54B	15.56B
South Korea Growth	75.75%	32.03%	-
Total	36.10B	20.54B	15.56B
Total Growth	75.75%	32.03%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error